Cargando…
Diagnostic biomarkers and aortic dissection: a systematic review and meta-analysis
BACKGROUND: Aortic dissection (AD) is a serious and fatal vascular disease. The earlier the condition of AD patients can be assessed precisely, the more scientifically controlled the patient’s condition will be. Therefore, timely and accurate diagnosis is significant for AD. Blood biomarker testing...
Autores principales: | Chen, Hongjian, Li, Yunjie, Li, Zheqian, Shi, Yanli, Zhu, Haobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563263/ https://www.ncbi.nlm.nih.gov/pubmed/37817089 http://dx.doi.org/10.1186/s12872-023-03448-9 |
Ejemplares similares
-
D-dimer as a Biomarker for Acute Aortic Dissection: A Systematic Review and Meta-analysis
por: Cui, Jia-sen, et al.
Publicado: (2015) -
Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis
por: Chen, Can, et al.
Publicado: (2022) -
Diagnostic accuracy of transthoracic echocardiography for the identification of proximal aortic dissection: a systematic review and meta-analysis
por: Sutarjono, Bayu, et al.
Publicado: (2023) -
Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis
por: Rawla, Prashanth, et al.
Publicado: (2019) -
The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis
por: Wee, Ian, et al.
Publicado: (2021)